{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":9,"sponsored":0,"items":[{"id":"n_wapii6vu6ljlaotfjblq","seq":1773556,"kind":"article","title":"近七成患者有症状才就医，胃癌早诊率低如何破局？","title_en":"Nearly 70% of patients only seek medical attention when symptomatic, how to break the deadlock in early gastric cancer diagnosis?","url":"https://www.chinanews.com.cn/jk/2026/10-05/10708094.shtml","summary":"中新网北京10月5日电(记者 赵方园)“早期消化系统肿瘤，尤其是早期胃癌，基本上没有症状。而等待症状出现，往往已错过最佳的发现时机。”近日，《中国胃癌患者生存质量白皮书》(以下简称《白皮书》)正式发布。作为《白皮书》领衔指导专家，北京大学肿瘤医院消化肿瘤内科主任沈琳接受了中新健康的采访。","published":"2026-10-05T05:17:36Z","seen":"2026-10-05T06:17:25Z","lang":"zh","country":"CN","source":{"id":"kite-chinanews-com-cn-8a8f8c","name":"chinanews.com.cn","domain":"chinanews.com.cn","outlet":{"wikidata":"Q969272","name":"China News Service","type":"news_agency","country":"CN","designations":["news agency","state media"]}},"via":"kite-chinanews-com-cn-8a8f8c","entities":[{"id":"Q189588","name":"stomach cancer","type":"other"}],"story":"st_wapii6vu6ljlaotfjblq","category":"health","category_p":0.95,"sentiment":"negative","tone":-0.27,"political":0.07},{"id":"n_p3b2o6w3vtt3dfn36ooa","seq":1586434,"kind":"article","title":"РИА Новости: причиной смерти Кашпировского стал рак желудка","title_en":"RIA Novosti: Cause of death of Kashpirovsky was stomach cancer","url":"https://russian.rt.com/russia/news/1690401-kashpirovskii-rak-zheludok","summary":"Причиной смерти Анатолия Кашпировского стал рак желудка четвёртой стадии, сообщил РИА Новости его племянник Юрий Мамаев. Читать далее","published":"2026-10-03T20:35:21Z","seen":"2026-10-03T21:01:25Z","lang":"ru","country":"RU","source":{"id":"kite-russian-rt-com-afb7cb","name":"russian.rt.com","domain":"russian.rt.com"},"via":"kite-russian-rt-com-afb7cb","authors":["RT на русском"],"entities":[{"id":"Q189588","name":"stomach cancer","type":"other"}],"image":"https://mf.b37mrtl.ru/russian/images/2026.10/thumbnail/6ac168f902e8bd4814053a20.jpg","story":"st_afezrtgrku75lhao7l3q","category":"health","category_p":0.52,"category2":"arts-culture-entertainment","sentiment":"negative","tone":-0.84,"political":0.2},{"id":"n_5wskac2hv6huu3bhkkga","seq":1456990,"kind":"article","title":"Nữ streamer qua đời ở tuổi 25 vì ung thư dạ dày: Những thói quen sinh hoạt đáng lưu ý","title_en":"Female streamer died at age 25 from stomach cancer: Lifestyle habits that may be harmful","url":"https://giadinh.suckhoedoisong.vn/nu-streamer-qua-doi-o-tuoi-25-vi-ung-thu-da-day-nhung-thoi-quen-sinh-hoat-dang-luu-y-172261002232136822.htm","summary":"GĐXH - Nữ streamer “Hy Hy Từ Bảo” qua đời ở tuổi 25 sau khi mắc ung thư dạ dày. Trước đó, cô từng chia sẻ về những thói quen sinh hoạt như thường xuyên thức khuya, ăn uống thất thường, uống cà phê và trà sữa.","published":"2026-10-03T00:57:57Z","seen":"2026-10-03T00:57:57Z","lang":"vi","country":"VN","source":{"id":"kite-giadinh-suckhoedoisong-vn-42a27d","name":"giadinh.suckhoedoisong.vn","domain":"giadinh.suckhoedoisong.vn"},"via":"kite-giadinh-suckhoedoisong-vn-42a27d","entities":[{"id":"Q189588","name":"stomach cancer","type":"other"}],"story":"st_auvo5yqveovrvpyq3sma","category":"health","category_p":0.42,"sentiment":"negative","tone":-0.38,"political":0.0},{"id":"n_fpngifjqrhqicmrnisza","seq":1449920,"kind":"article","title":"25歲網紅胃癌離世生前一組習慣曝光","url":"https://www.weekendhk.com/%e7%9f%9a%e7%9b%ae%e8%a9%b1%e9%a1%8c/%e7%b6%b2%e7%b4%85%e7%86%b1%e8%a9%b1-%e8%83%83%e7%99%8c%e8%ad%a6%e8%99%9f-%e5%81%a5%e5%ba%b7%e7%94%9f%e6%b4%bb-3516846","summary":"內地網紅「嘻嘻徐寶」徐女士年僅25歲，曾公開早期胃癌確診經歷，惟其社交平台近日傳出離世消息。她生前披露一連串作息及飲食習慣，當中兩餐竟可相隔約10小時，這番健康告誡如今更顯沉重。 每日兩餐相隔十小時生活節奏曝光 徐女士於2025年分享患癌經歷，坦言確診初期難以接受，不明白自己二十多歲為何會患上胃癌。她憶述過往經常熬夜，每日一般只吃兩餐，早上約8時進食後，要到下午6時才再吃東西；平日又偏愛咖啡、奶茶及汽水，蔬菜與水果攝取較少。她同時提到外婆曾於70歲因食道癌離世，因此不排除家族因素可能帶來影響，但強調自己無法確認確切病因。 消息曝光後生活習慣成輿論焦點 事件曝光後，輿論焦點隨即落在她曾披露的生活模式上，熬夜、三餐欠規律及少吃蔬果等細節尤其刺眼。不過，徐女士生前並未把患癌原因歸咎於任何單一習慣，而是以個人經歷提醒網民重視身體狀況及維持規律作息；這份分享並非為自己下定論，卻把不少都市人習以為常的生活盲點再次推到公眾眼前。 公開確診經歷一年後最終傳來噩耗…","published":"2026-10-02T23:13:58Z","seen":"2026-10-02T23:54:48Z","lang":"en","country":"HK","source":{"id":"kite-weekendhk-com-451c0c","name":"weekendhk.com","domain":"weekendhk.com","outlet":{"wikidata":"Q11081097","name":"Weekend Weekly","type":"magazine","designations":["magazine"]}},"via":"kite-weekendhk-com-451c0c","topics":["矚目話題","健康生活","網紅熱話","胃癌警號"],"authors":["新假期編輯部"],"entities":[{"id":"Q189588","name":"stomach cancer","type":"other"}],"story":"st_qq5aivcrmj7ajf5xxspa","category":"health","category_p":0.37,"category2":"lifestyle-leisure","sentiment":"negative","tone":-0.34,"political":0.0},{"id":"n_s3yfdok32pdrwnhfkn5a","seq":923492,"kind":"article","title":"Nữ blogger nổi tiếng qua đời ở tuổi 25 vì ung thư dạ dày: Ai cũng giật mình khi biết món \"khoái khẩu\" của cô ấy...","title_en":"Famous female blogger dies at 25 from stomach cancer: Everyone is shocked to learn about her 'favorite food'...","url":"https://soha.vn/nu-blogger-noi-tieng-qua-doi-o-tuoi-25-vi-ung-thu-da-day-ai-cung-giat-minh-khi-biet-mon-khoai-khau-cua-co-ay-198260930183028722.htm","summary":"Sự ra đi đột ngột của một blogger trẻ tuổi sau chuỗi ngày kiên cường chống chọi với căn bệnh ung thư dạ dày đã gióng lên hồi chuông cảnh báo tàn khốc về những món \"khoái khẩu\" của người trẻ hiện đại.","published":"2026-09-30T14:15:03Z","seen":"2026-09-30T14:15:03Z","lang":"vi","country":"VN","source":{"id":"kite-soha-vn-2373ca","name":"soha.vn","domain":"soha.vn"},"via":"kite-soha-vn-2373ca","entities":[{"id":"Q189588","name":"stomach cancer","type":"other"}],"story":"st_jtc3rkolcsiwfp252dta","category":"arts-culture-entertainment","category_p":0.39,"category2":"lifestyle-leisure","sentiment":"negative","tone":-0.41,"political":0.03},{"id":"n_3xs2othe6emzq7vpmqwa","seq":814926,"kind":"article","title":"희귀 폐암·위암·요로상피암 치료제, 10월부터 건강보험 적용 확대","title_en":"A rare treatment for lung cancer, stomach cancer, and urothelial carcinoma will be expanded to be covered by health insurance from October","url":"https://www.mt.co.kr/thebio/2026/09/30/2026093008285868004","summary":"레테브모·빌로이 신규 급여…파드셉·키트루다 병용도 1차 치료부터 적용 서로 다른 제약사 신약 간 병용 급여 사실상 첫 사례…정부, 제도 개선 추진 희귀 유전자 변이 폐암과 진행성·전이성 위암, 요로상피암 환자가 사용하는 항암제에 10월부터 건강보험이 적용된다. 특히 서로 다른 제약사가 개발한 신약 2종의 병용요법에도 보험급여가 적용되면서 항암제 치료 선택지가 확대된다. 보건복지부는 건강보험정책심의위원회는 희귀·소외암 환자의 치료 접근성을 높이기 위해 항암제 3개 요법의 건강보험 적용 확대를 의결했다고 30일 밝혔다. 적용 시점은 내달 1일이다. 대상은 희귀 유전자 변이 폐암 등의 치료제 '레테브모캡슐', 진행성·전이성 위암 치료제 '빌로이주', 요로상피암 치료에 사용하는 '파드셉주·키트루다주' 병용요법이다.","published":"2026-09-30T03:00:00Z","seen":"2026-09-30T03:48:16Z","lang":"ko","country":"KR","source":{"id":"kite-mt-co-kr-9de042","name":"mt.co.kr","domain":"mt.co.kr","outlet":{"wikidata":"Q12595017","name":"Money Today","type":"newspaper","country":"KR","designations":["media company","newspaper"]}},"via":"kite-mt-co-kr-9de042","topics":["thebio"],"authors":["정기종 기자"],"entities":[{"id":"Q334911","name":"health insurance","type":"org"},{"id":"Q47912","name":"lung cancer","type":"other"},{"id":"Q189588","name":"stomach cancer","type":"other"},{"id":"Q2501186","name":"transitional cell carcinoma","type":"other"}],"image":"https://thumb.mt.co.kr/21/2026/09/2026093008285868004_1.jpg","story":"st_3xs2othe6emzq7vpmqwa","category":"health","category_p":0.87,"sentiment":"neutral","tone":0.36,"political":0.13},{"id":"n_r6vsiibxuktecuvtvwna","seq":777187,"kind":"article","title":"위암 신약 늘어나는데 동반진단은 '1약 1검사'…위암학회 \"호환성 인정해야\"","title_en":"New stomach cancer drugs are increasing, but companion diagnostics are 'one drug, one test'... Stomach cancer society 'compatibility recognition' needed","url":"https://www.bosa.co.kr/news/articleView.html?idxno=3012966","summary":"[의학신문·일간보사=이재원 기자] 졸베툭시맙(상품명 빌로이)을 시작으로 CLDN18.2를 표적하는 항체약물접합체(ADC)와 이중항체 등 위암 신약 개발이 확대되면서, 치료제마다 별도의 동반진단 검사를 요구하는 현행 제도를 보다 유연하게 운영해야 한다는 전문가 의견이 제기됐다.동일한 바이오마커를 대상으로 하는 검사라도 항체 클론이나 검사 플랫폼, 판독 기준 등이 달라 단순히 서로 대체해서 사용할 수는 없지만, 비교연구를 통해 분석적·임상적 동등성이 입증된 경우에는 기존 검사의 적용 범위를 다른 치료제로 확대할 수 있는 제도적 경로를","published":"2026-09-29T21:00:00Z","seen":"2026-09-29T22:28:45Z","lang":"ko","source":{"id":"kite-bosa-co-kr-134b8e","name":"bosa.co.kr","domain":"bosa.co.kr","outlet":{"wikidata":"Q20445876","name":"Q20445876","type":"newspaper","country":"KR","designations":["newspaper"]}},"via":"kite-bosa-co-kr-134b8e","topics":["medicine","의원·병원"],"authors":["이재원 기자"],"entities":[{"id":"Q189588","name":"stomach cancer","type":"other"}],"story":"st_r6vsiibxuktecuvtvwna","category":"health","category_p":0.86,"sentiment":"neutral","tone":-0.02,"political":0.11},{"id":"n_34idnvp5q4st3mfqn4uq","seq":597562,"kind":"article","title":"Artificial intelligence-based tongue image analysis for non-invasive screening of gastric cancer, precancerous lesions, and related gastrointestinal disorders: a systematic review","url":"https://www.frontiersin.org/articles/10.3389/fmed.2026.1931256","summary":"BackgroundGastric cancer remains a major cause of cancer-related mortality, largely because many cases are diagnosed at an advanced stage. Upper gastrointestinal endoscopy with histopathological confirmation is the diagnostic gold standard, but its invasiveness, cost, and limited accessibility restrict population-level use. Artificial intelligence (AI)-based tongue-image analysis may provide an objective, low-cost, and non-invasive adjunct for pre-endoscopic risk…","published":"2026-09-29T06:38:29Z","seen":"2026-09-29T06:38:29Z","lang":"en","source":{"id":"kite-frontiersin-org-1f929d","name":"frontiersin.org","domain":"frontiersin.org","outlet":{"wikidata":"Q80796","name":"Frontiers Media","type":"other","country":"CH","designations":["academic publisher","open-access publisher","organization"]}},"via":"kite-frontiersin-org-1f929d","topics":["medicine","systematic review"],"authors":["author"],"entities":[{"id":"Q189588","name":"stomach cancer","type":"other"},{"id":"Q74454586","name":"Precancerous lesions","type":"other"},{"id":"Q64432026","name":"Gastrointestinal Disorders","type":"other"},{"id":"Q1504425","name":"systematic review","type":"other"}],"story":"st_34idnvp5q4st3mfqn4uq","category":"science-technology","category_p":0.56,"category2":"health","sentiment":"neutral","tone":0.09,"political":0.07},{"id":"n_3ttetgcegmixd4ejy46a","seq":335247,"kind":"article","title":"Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer","url":"https://www.thailand-business-news.com/pr-news/akeso-announces-first-patient-enrolled-in-global-phase-iii-trial-of-cadonilimab-versus-nivolumab-in-first-line-gastric-cancer","published":"2026-09-28T03:43:19Z","seen":"2026-09-28T03:43:19Z","lang":"en","source":{"id":"thailand-business-news.com","name":"thailand-business-news.com","domain":"thailand-business-news.com","outlet":{"wikidata":"Q120063840","name":"Thailand Business News","type":"newspaper","country":"TH","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["education","economy","politics","science"],"entities":[{"id":"Q132735866","name":"Akeso","type":"org"},{"id":"Q123585479","name":"cadonilimab","type":"other"},{"id":"Q7041828","name":"nivolumab","type":"other"},{"id":"Q189588","name":"stomach cancer","type":"other"}],"story":"st_3ttetgcegmixd4ejy46a","category":"health","category_p":0.67,"sentiment":"positive","tone":0.07,"political":0.06}]}